WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated
IVD
News
The EOI for human insulin now revised to include long-acting insulin analogues
M
The changes to the EOI for human insulin shown below in bold and italic
First isoniazid/rifapentine generic prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s cycloserine capsule prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Macleods’ pyridoxine tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Publication of the Second Edition of the Manual on development and use of FAO and WHO specifications for chemical pesticides
VCP
WHO and FAO are pleased to announce the publication of the second edition of the Manual on development and use of FAO and WHO specifications for chemical pesticides.
Atazanavir/ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Trastuzumab 440mg co-packed with bacteriostatic water for injection for multiple dosing prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Paediatric dispersible abacavir/lamivudine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Micro Labs’ dolutegravir/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Withdrawal of Vector Control TC products and the corresponding reference profiles supporting WHO Specifications
VCP
Recently, seven active ingredient Technical Material (TC) products, previously evaluated by WHO, were withdrawn by the recognized applicants. In so doing, the appli
ITN Product Review Report
VCP
WHO PQT/VCP recently published the following report - Product Review Report - Insecticide Treated Nets Formulated with Pyrethroid+PBO and Pyrethroid+2nd Ac
Gilead’s remdesivir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First nirmatrelvir + ritonavir prequalified for Covid-19
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
M
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Revised Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases published
M
The 20th Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases, is published with the following changes:
A) The followin
Hetero’s ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Two PQT Medicines trainings for regulators in 2022
M
Two PQT Medicines (virtual) trainings for regulators will take palce during June 2022.
Zhejiang Apeloa’s levofloxacin tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Suspension of supply of COVID-19 vaccine (COVAXIN®)
V
The World Health Organization (WHO) is today confirming the suspension of supply of Covaxin produced by Bharat, through UN procurement agencies and recommending to countries that received the vacci
COVID-19 PANDEMIC AND EMERGENCY USE LISTING
IVD
Emergency Use Listing (EUL) for candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2 remains ongoing.